Navigation Links
Endo Pharmaceuticals Reports Second Quarter Revenues and Updates Financial Guidance, Reflecting the Acquisition of American Medical Systems
Date:8/9/2011

cipal amount of 7% senior unsecured notes due 2019 at an issue price of par and $400 million aggregate principal amount 7 1/4% senior unsecured notes due 2022 at an issue price of par (collectively, the "notes") in connection with the previously announced private offering.

On June 17, 2011, we established a $1.5 billion, five-year senior secured term loan facility (the Term Loan A Facility) and a $700 million, seven-year senior secured term loan facility (the Term Loan B Facility).

The net proceeds of the notes offerings, together with cash on hand and borrowings under Endo's new credit facility, were used to finance Endo's acquisition of AMS, refinance Endo's existing credit facility and existing AMS indebtedness, as well as pay related fees and expenses.

Approval of Generic ProductsOn May 18, 2011, we received approval from the FDA for dexamethasone elixir, USP, 0.5 mg/ 5 mL and Orsythia™ Tablets (levonorgestrel and ethinyl estradiol tablets, USP, 0.1 mg/0.02 mg). On June 3, 2011 we received approval from the FDA for telmisartan/HCTZ tablets.

Conference Call InformationEndo will conduct a conference call with financial analysts to discuss this news release today at 8:30 a.m. ET.  Investors and other interested parties may call 866-203-2528 (domestic) or 617-213-8847 (international) and enter passcode 76257989.  Please dial in 10 minutes prior to the scheduled start time.

A replay of the call will be available from August 9 at 12:00 p.m. ET until 12:30 p.m. ET on August 23, 2011 by dialing 888-286-8010 (domestic) or 617-801-6888 (international) and entering passcode 82161745.

A simultaneous webcast of the call may be accessed by visiting www.endo.com.  In addition, a replay of the webcast will be available until 12:00 p.m. ET on August 23, 2011.  The replay can be accessed by clicking on "Events" in the Investor Relations section of the website.


'/>"/>

SOURCE Endo Pharmaceuticals
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

Related medicine technology :

1. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
2. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
3. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
4. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
5. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
6. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
7. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
8. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
9. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
10. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
11. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2015)... Massachusetts y LONDRES, August 29, 2015 /PRNewswire/ ... Inteligencia Anatómica para los sistemas de ... reproducibles en Ecografía, tiempos de examen rápidos y ... traduce en mayor confianza diagnóstica en el proceso de ...  (NYSE: PHG, AEX: PHIA) ha anunciado hoy el lanzamiento ...
(Date:8/28/2015)... India , August 28, 2015 ... Biomarker Market by Tumor (Breast, Lung, Prostate) Type (Protein ... Application (Diagnostic, Drug Discovery, Prognostic) & Geography - Global ... Market is expected to reach around 17,689.0 Million USD ... forecast period of 2015 to 2020. ...
(Date:8/28/2015)... Aug. 28, 2015 Research ... of the "Investigation Report on China,s Tobramycin Market, ... is a traditional antibiotic whose eye drop and ointment ... of potential infection or inflammation caused by eye infection. ... are able to produce tobramycin, among which the ...
Breaking Medicine Technology:Philips presenta HeartModel A.I en el Congreso ESC 2015 2Philips presenta HeartModel A.I en el Congreso ESC 2015 3Philips presenta HeartModel A.I en el Congreso ESC 2015 4Philips presenta HeartModel A.I en el Congreso ESC 2015 5Cancer Biomarkers Market Worth 17,689.0 Million USD by 2020 2Cancer Biomarkers Market Worth 17,689.0 Million USD by 2020 3Cancer Biomarkers Market Worth 17,689.0 Million USD by 2020 4Cancer Biomarkers Market Worth 17,689.0 Million USD by 2020 5Investigation Report on China's Tobramycin Market, 2015-2019 2
... - Early Renewal of the Agreement to ... - Expansion of the Scope of the Collaboration to Include ... Commercial Terms and Payments to ExonHit if Allergan,Sublicenses to a ... ALEHT) today announced a reinforcement,of its existing drug discovery collaboration ...
... MITI ), a biopharmaceutical company developing novel, ... diseases,provides an outlook on key events anticipated for the ... to provide an update on its research and development,programs ... -- April 12 to 16, 2009: Update on several ...
Cached Medicine Technology:ExonHit Therapeutics Expands Strategic Collaboration With Allergan 2ExonHit Therapeutics Expands Strategic Collaboration With Allergan 3ExonHit Therapeutics Expands Strategic Collaboration With Allergan 4Micromet Key Events for 2009 2Micromet Key Events for 2009 3Micromet Key Events for 2009 4Micromet Key Events for 2009 5
(Date:8/31/2015)... ... August 31, 2015 , ... “My mother and husband use oxygen therapy and ... “I thought there could be a comfortable way to prevent the irritation, so I ... Protector offers a more secure way to anchor the cannula tubing used in oxygen ...
(Date:8/31/2015)... ... , ... For 12 years, since 2004, the Mesothelioma Applied Research Foundation ... Day . On this day, and in the weeks leading up to it, the ... the cause. , “One of the ways a person can be involved is by ...
(Date:8/31/2015)... , ... August 31, 2015 , ... ... in and around Grand Prairie, is teaming up with the Tarrant County chapter ... area. , Meals on Wheels is the oldest and largest national organization that ...
(Date:8/31/2015)... Va. (PRWEB) , ... August 31, 2015 , ... ... the nation’s leading nonprofit authority on the use of health IT to create ... annual fall conference, WEDI-Con 2015 . Taking place at the Hyatt Regency ...
(Date:8/31/2015)... , ... August 31, 2015 , ... Juvent Sports ( ... list of major sports figures who are finding joint pain relief after using their ... #1 men’s tennis player in the world said, “For the first time in over ...
Breaking Medicine News(10 mins):Health News:InventHelp® Inventor Designs Nasal Cannula Ear Protector (AVZ-1217) 2Health News:Cancer Research Organization Paints the World in Mesothelioma Awareness 2Health News:Cancer Research Organization Paints the World in Mesothelioma Awareness 3Health News:Westchester Insurance and the Meals on Wheels Association Announce Joint Charity Effort to Provide Nutritious Meals for Senior Citizens 2Health News:Westchester Insurance and the Meals on Wheels Association Announce Joint Charity Effort to Provide Nutritious Meals for Senior Citizens 3Health News:WEDI Announces Program for Annual Fall Conference: WEDI-Con 2015 2Health News:WEDI Announces Program for Annual Fall Conference: WEDI-Con 2015 3Health News:Mats Wilander, 7 Grand Slam Title Winner and Tennis Legend, Now Plays Without Joint Pain 2Health News:Mats Wilander, 7 Grand Slam Title Winner and Tennis Legend, Now Plays Without Joint Pain 3
... Most Current FindingsBAYSIDE, N.Y., May 28 Once ... renowned scientists and medical experts on Tourette Syndrome ... involuntary movements and sounds -- convene to disseminate ... this baffling condition.As part of its basic mission ...
... not appear to hamper cardiovascular health , , THURSDAY, ... not hamper cardiovascular fitness, regardless of the type of ... U.S. study says. , Researchers from Georgetown University ... giving a three-minute step test to 49 diverse women ...
... with Patients in All Phases of CareJERSEY CITY, ... empowering patients and aiding healthcare providers in improving ... of strategic healthcare consultants specializing in collaborative medical ... service called Patient Centered CME(TM) (PC-CME(TM), PCCME(TM)). Dora ...
... in combination with a conventional prostate-specific antigen (PSA) screening ... could eliminate tens of thousands of unneeded, painful, and ... by researchers at Dana-Farber Cancer Institute. , At the ... in Orlando, Fla., William K. Oh, M.D., and Robert ...
... 28 Now, no matter when a patient with ... support, a Spanish-speaking representative is available to help. Insulet ... tubing-free insulin pump technology with its OmniPod System, has ... hours a day, seven days a week."Managing diabetes is ...
... Streamline Health Solutions, Inc. (Nasdaq: STRM ... expansion plans, the Company,s document workflow solutions will ... for multiple facilities within an additional leading Canadian ... provide a consolidated view into a patient,s complete ...
Cached Medicine News:Health News:5th International Scientific Symposium on Tourette Syndrome to Focus on Latest Research and Treatment 2Health News:5th International Scientific Symposium on Tourette Syndrome to Focus on Latest Research and Treatment 3Health News:Cancer Survivors Can Still Be Fit, Study Asserts 2Health News:Gullapalli & Associates Launches First-of-Its-Kind Patient Centered CME(TM) (PCCME(TM)) Service, Names Dora Ochsenbein Manager of Educational Planning 2Health News:Gullapalli & Associates Launches First-of-Its-Kind Patient Centered CME(TM) (PCCME(TM)) Service, Names Dora Ochsenbein Manager of Educational Planning 3Health News:Gullapalli & Associates Launches First-of-Its-Kind Patient Centered CME(TM) (PCCME(TM)) Service, Names Dora Ochsenbein Manager of Educational Planning 4Health News:New blood test greatly reduces false-positives in prostate cancer screening 2Health News:Spanish-Speaking OmniPod Customer Support Now Available Around-the-Clock 2Health News:Spanish-Speaking OmniPod Customer Support Now Available Around-the-Clock 3Health News:Streamline Health Document Workflow Solution to be Integrated Into Electronic Medical Records System for Leading Canadian Healthcare Region 2Health News:Streamline Health Document Workflow Solution to be Integrated Into Electronic Medical Records System for Leading Canadian Healthcare Region 3
... Laparoscopic Instruments incorporate a layered design unique ... and monitored to prevent stray electrosurgical burns ... by insulation failure or capacitive coupling; a ... built into all AEM Instruments provides a ...
SOLOS Endoscopy shares your commitment to provide every patient with the highest quality care available through our ongoing research and development of advanced surgical instruments and diagnostic so...
... single-use laparoscopic fan retractor has application ... indicated for endoscopic surgery and may ... insufflation., ,The Laparofan™ single-use V-shaped ... be used in conjunction with the ...
The ENDO MINI-RETRACT™ 5 mm instrument has application in a variety of gynecologic, abdominal, urologic, thoracic and endoscopic procedures for temporary retraction of tissue and small tubular ...
Medicine Products: